Skip to main content
Rashmi Verma, MD, Oncology, Sacramento, CA

Rashmi Verma MD FACP

Hematologic Oncology


Physician

Join to View Full Profile
  • 4501 X StreetUC Davis Cancer CenterSacramento, CA 95817

  • Phone+1 916-734-3772

  • Fax+1 916-734-7953

Dr. Verma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Texas Tech University Health Sciences Center at Lubbock
    Texas Tech University Health Sciences Center at LubbockFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2011 - 2012
  • University of South Dakota
    University of South DakotaResidency, Internal Medicine, 2009 - 2011
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2026
  • TX State Medical License
    TX State Medical License 2015 - 2026
  • NY State Medical License
    NY State Medical License 2019 - 2021
  • AR State Medical License
    AR State Medical License 2018 - 2020
  • NJ State Medical License
    NJ State Medical License 2012 - 2013
  • SD State Medical License
    SD State Medical License 1900 - 2012
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chief Fellow, Hematology and Oncology Texas Tech University, 2013-2016
  • Texas Society of Clinical Oncology 2014 Poster Texas Society of Clinical Oncology, 2014
  • ASCO poster 2014 American Society of Clinical Oncology, 2014

Publications & Presentations

PubMed

Journal Articles

  • Cancer testis antigens:Potential new targets for lung cancer  
    MirandolaL., RiazJ., VermaR, Journal of Clinical Oncology
  • Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer  
    Verma R., Riaz J., alJournal of Clinical Oncology
  • Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium  
    Mirandola L1, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M, Int Rev Immunol
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Galectin 3C Inhibits Tumor Growth and Increases the Anticancer Activity of Taxol in vitro Murine Model of Ovarian Cancer
    Rashmi Verma, Texas Clinical Society San Antonio, San Antonio
  • . Effect of the novel galectin-3 blocker, Gal3M, on the efficacy and reduction of toxicity of proteosome inhibitors for the treatment of multiple myeloma
    Riaz J., Verma R., Mirandola L et al, ASCO, e abstract
  • Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer.
    Verma R, Riaz J, ASCO, e abstract, 1/1/2014
  • Join now to see all

Other

Press Mentions

  • Colon and Rectal Cancer on the Rise in Young Adults
    Colon and Rectal Cancer on the Rise in Young AdultsMarch 9th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: